Try Alerts Free   |   Login
Health Care › PHARMACEUTICAL PREPARATIONS

MRVI Price Correlated With Financials For Maravai LifeSciences Holdings

Free historical financial statements for Maravai LifeSciences Holdings Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 6 quarters since 2021. Compare with MRVI stock chart to see long term trends.

MRVI Stock Compared to Quarterly

MRVI Income Statement

Revenue, Net:242732000
Revenue Per Share:1.8455
Cost of Goods & Services Sold:37496000
Selling, General & Admin Expense:28061000
Research & Development Expense:4274000
Total Operating Expenses:62031000
Operating Income:180701000
Income Taxes:18271000
Net Income:156721000
Earnings Per Share, Basic:0.54
Shares Outstanding, Basic Avg:131524000

MRVI Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:115000
Net Cash from Operations:164279000
Net Cash from Operations Per Share:1.249
Issuance of Long-term Debt:0
Net Cash from Financing Activities:-43411000
Property, Plant & Equipment Purchases:1661000
Purchases of Businesses, Net of Cash:0
Net Cash from Investing Activities:-1661000
Net Change in Cash & Equivalents:119207000

MRVI Balance Sheet

Cash and Cash Equivalents:550676000
Accounts Receivable, Net:120354000
Inventories:60113000
Total Current Assets:759382000
Property, Plant & Equipment, Net:46956000
Total Assets:2171799000
Accounts Payable:23267000
Current Portion of Long-Term Debt:5440000
Total Short-Term Liabilities:112530000
Long Term Debt, Non-Current Portion:523655000
Total Liabilities:1398007000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
GTCR LLC
21,681,033 sh
 
$764,690
Vanguard Group Inc
10,512,217 sh
-21,392 sh
0%
$370,766
-$70,593
FMR LLC
9,439,990 sh
-3,267,656 sh
-26%
$332,948
-$199,502
Massachusetts Financial Services Co /Ma/
8,965,103 sh
962,082 sh
12%
$316,198
-$19,128
Blackrock Inc.
5,981,894 sh
-71,153 sh
-1%
$210,981
-$42,641
Ownership Capital B.V.
4,205,521 sh
750,265 sh
22%
$148,329
$3,554
Champlain Investment Partners, LLC
3,582,530 sh
28,405 sh
1%
$126,356
-$22,562
JPMorgan Chase & Co
3,394,600 sh
-116,607 sh
-3%
$119,728
-$27,392
Morgan Stanley
2,843,021 sh
322,568 sh
13%
$100,273
-$5,334
Clearbridge Investments, LLC
2,430,615 sh
-235,082 sh
-9%
$85,728
-$25,965
Citigroup Inc
1,525,222 sh
247,667 sh
19%
$53,794
$264
Geode Capital Management, LLC
1,480,580 sh
54,286 sh
4%
$52,220
-$7,541
Artemis Investment Management Llp
1,315,608 sh
112,878 sh
9%
$46,284
-$4,121
Ardevora Asset Management Llp
1,302,694 sh
-108,512 sh
-8%
$45,946
-$13,184
Invesco Ltd.
1,227,783 sh
-112,851 sh
-8%
$43,304
-$12,868
Natixis
1,000,000 sh
1,000,000 sh
NEW
$35,270
$35,270
Renaissance Technologies LLC
913,200 sh
368,400 sh
68%
$32,209
$9,382
Blair William & Co
708,400 sh
-4,348 sh
-1%
$24,985
-$4,879
Allspring Global Investments Holdings, LLC
683,917 sh
 
$28,655
Vaughan Nelson Investment Management, L.P.
617,685 sh
617,685 sh
NEW
$21,785
$21,785

Data imported from Maravai LifeSciences Holdings Inc. SEC filings. Check original filings before making any investment decision.